研究单位：[1]The First Affiliated Hospital of Guangzhou Medical University[2]Beijing Cancer Hospital Peking,Beijing,China,100000[3]Beijing Chest Hospital,Capital Medical university Peking,Beijing,China,100000[4]Peking Union Medical College Hospital Peking,Beijing,China,100000[5]Peking University People'S Hospital Peking,Beijing,China,100000[6]Peking University Third Hospital Peking,Beijing,China,100000[7]Xuanwu Hospital Capital Medical University Peking,Beijing,China,100000[8]Chongqing Cancer Hospital Chongqing,Chongqing,China,400000[9]Fujian Provincial Hospital Fuzhou,Fujian,China,350000
研究目的：
This study is a prospective, national, multi-center, non-interventional study. The main purpose is to explore the initial adjuvant treatment pattern after radical resection for early-stage NSCLC patients with EGFR Mutation-Positive in the real world. The secondary purpose was to observe the postoperative follow-up treatment pattern and its subgroups (based on different EGFR mutation status and different clinical stages).
